论文部分内容阅读
近来,欧阳信似乎显得有些疲惫,这与以前在记者面前所表现出的那份意气风发有着天壤之别。作为一家在业界颇具影响力的医药批发公司负责人,欧阳信必须时刻倾听上游和下游的不同声音,以便调整经营策略。就在默沙东公司宣布对“万络”实施召回的当天晚上,欧阳信立刻召开公司中高层会议,讨论这次召回所带来的影响。虽然,药品本身可退回厂家,但欧阳信必须为由此产生的流通和管理费用买单。“说实话,我们支持药品召回,这是企业经营的诚信问题。”但让他心烦的是医药流通企业低利润的趋势越来越明显,应如何规避类似事件所增加的成本?直到现在,欧阳信还在思考。
Recently, Ouyang Xin seems a bit exhausted, which is far different from the high-spirited hair style shown before reporters. As an influential pharmaceutical wholesale company leader in the industry, Ouyang Xin must always listen to the different voices of the upstream and downstream in order to adjust its business strategy. Earlier in the day Merchudong announced the recall of “Wanluo”, Ouyang Xin immediately held a mid-level meeting of the company to discuss the impact of the recall. Although the drug itself can be returned to manufacturers, but Ouyang Xin must pay the circulation and management costs incurred. “To be honest, we support the recall of drugs, which is the issue of integrity of business operations.” But he was upset that the trend of low profits of pharmaceutical distribution companies more and more obvious, how to avoid the cost of similar incidents? Until now, Ouyang The letter is still thinking.